Conditions: Type 2 Diabetes Mellitus
Keywords: insulin resistance
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 203
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of MP-513 (Teneligliptin) in patients with type 2 Diabetes for 12 weeks administration.

Detailed description:

Arms:
arm 1: Teneligliptin 20 mg, orally, once daily arm 2: Teneligliptin placebo-matching tablets, orally, once daily

Interventions: intervention 1: Teneligliptin 20 mg intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: